Vivo Ventures Vii, Llc - Net Worth and Insider Trading
Vivo Ventures Vii, Llc Net Worth
The estimated net worth of Vivo Ventures Vii, Llc is at least $11 Million dollars as of 2024-11-13. Vivo Ventures Vii, Llc is the 10% Owner of Aclaris Therapeutics Inc and owns about 4,191,397 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $11 Million. Vivo Ventures Vii, Llc is also the 10% Owner of MEI Pharma Inc and owns about 158,155 shares of MEI Pharma Inc (MEIP) stock worth over $496,607. Details can be seen in Vivo Ventures Vii, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Vivo Ventures Vii, Llc has not made any transactions after 2015-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Vivo Ventures Vii, Llc
Vivo Ventures Vii, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivo Ventures Vii, Llc owns 4 companies in total, including Sierra Oncology Inc (SRRA) , Codexis Inc (CDXS) , and Aclaris Therapeutics Inc (ACRS) among others .
Click here to see the complete history of Vivo Ventures Vii, Llc’s form 4 insider trades.
Insider Ownership Summary of Vivo Ventures Vii, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRRA | Sierra Oncology Inc | 2015-07-15 | 10 percent owner |
| CDXS | Codexis Inc | 2015-03-20 | 10 percent owner |
| ACRS | Aclaris Therapeutics Inc | 2015-10-13 | 10 percent owner |
 | | 2015-11-09 | 10 percent owner |
Vivo Ventures Vii, Llc Latest Holdings Summary
Vivo Ventures Vii, Llc currently owns a total of 2 stocks. Among these stocks, Vivo Ventures Vii, Llc owns 4,191,397 shares of Aclaris Therapeutics Inc (ACRS) as of October 13, 2015, with a value of $11 Million and a weighting of 95.56%. Vivo Ventures Vii, Llc also owns 158,155 shares of MEI Pharma Inc (MEIP) as of November 9, 2015, with a value of $496,607 and a weighting of 4.44%.
Latest Holdings of Vivo Ventures Vii, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2015-10-13 | 4,191,397 | 2.55 | 10,688,062 |
| MEIP | MEI Pharma Inc | 2015-11-09 | 158,155 | 3.14 | 496,607 |
Holding Weightings of Vivo Ventures Vii, Llc
Vivo Ventures Vii, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivo Ventures Vii, Llc has made a total of 0 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years. The most-recent trade in Aclaris Therapeutics Inc is the acquisition of 454,545 shares on October 13, 2015, which cost Vivo Ventures Vii, Llc around $5 Million.
According to the SEC Form 4 filings, Vivo Ventures Vii, Llc has made a total of 0 transactions in MEI Pharma Inc (MEIP) over the past 5 years. The most-recent trade in MEI Pharma Inc is the sale of 19,529 shares on November 9, 2015, which brought Vivo Ventures Vii, Llc around $718,652.
Insider Trading History of Vivo Ventures Vii, Llc
- 1
Vivo Ventures Vii, Llc Trading Performance
GuruFocus tracks the stock performance after each of Vivo Ventures Vii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vivo Ventures Vii, Llc is 89.49%. GuruFocus also compares Vivo Ventures Vii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Vivo Ventures Vii, Llc within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vivo Ventures Vii, Llc's insider trading performs compared to the benchmark.
Performance of Vivo Ventures Vii, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 39.22 | | | | | |
| Relative Return to S&P 500(%) | 36.14 | | | | | |
Vivo Ventures Vii, Llc Ownership Network
Ownership Network List of Vivo Ventures Vii, Llc
Ownership Network Relation of Vivo Ventures Vii, Llc
Vivo Ventures Vii, Llc Owned Company Details
What does Sierra Oncology Inc do?
Who are the key executives at Sierra Oncology Inc?
Vivo Ventures Vii, Llc is the 10 percent owner of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .
Sierra Oncology Inc (SRRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sierra Oncology Inc Insider Transactions
Vivo Ventures Vii, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Vivo Ventures Vii, Llc. You might contact Vivo Ventures Vii, Llc via mailing address: 505 Hamilton Avenue, Suite 200, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
